Michigan Vascular Access, PC (MVA) is a professional surgical practice created to bring high-quality vascular access services and the latest in research and industry progress to the hemodialysis patients of Southeast Michigan.Michigan Vascular Access sees patients from over one hundred dialysis units all over Southeast Michigan and extending from Battle Creek and Kalamazoo to Monroe, to Flint and Lapeer, Fowlerville and Fenton, Muskegon and beyond. Michigan Vascular Access is a true regional surgical practice.
Dr. Webb is an American Board of Surgery certified surgeon with experience in providing and maintaining effective vascular access for hemodialysis patients: from initial long-range planning and provision of the optimal first access in new dialysis patients, to maintenance, and rescue of dysfunctional or failed accesses. Open surgical and endovascular techniques are employed by a board-certified surgeon in a C-arm fluoroscope-equipped operating room, always with anesthesia support, and always in a JCAHO-accredited hospital.
Dr. Webb completed a Multi-Organ Transplant Fellowship at the Thomas Starzl Transplant Institute at the University of Pittsburgh (1992-1994) after a surgical residency at Henry Ford Hospital (1987-1992), followed by three years as an academic surgeon at the University of Miami, three years as a community surgeon in Illinois, and then three years as the Head of the Vascular Access Program at Henry Ford Hospital. He left Henry Ford in late 2003 to found Michigan Vascular Access, PC. Dr. Webb’s practice is currently limited to the care of patients who require solution of their hemodialysis access needs and problems.
Michigan Vascular Access uses the National Kidney Foundation Dialysis Outcomes Quality Initiative (NKF-DOQI) evidence-based guidelines to help us provide defensible and up-to-date dialysis access care. The DOQI guidelines have been boiled down to three main points: (1) provision of fistulas in all eligible patients, (2) avoiding or limiting catheter usage to avoid damage to the major veins, and (3) monitoring of access performance with pre-emptive intervention to avoid access loss. These three provisions drive much of our decision-making processes.
Michigan Vascular Access uses a “case management” approach to the care of the dialysis patient. We follow patients over time as much as possible, including episodic care delivered elsewhere, in order to provide the most logical long-term management. This demands more staff time, and is more expensive to provide, but leads to long term benefits to the patient.
Focusing on Fistulas and Vascular Access Solutions for Southeast Michigan.